Question 1

What is market sentiment?

Accepted Answer

Market sentiment is the overall attitude of investors toward a particular security or the financial market as a whole. It reflects whether investors are feeling bullish (optimistic) or bearish (pessimistic) based on price action, news flow, economic indicators, and collective psychology. Kinvestor tracks real-time market sentiment across major indices and individual equities.

Question 2

How does financial news affect stock prices?

Accepted Answer

Financial news affects stock prices by shifting investor sentiment. Positive earnings reports, strong economic data, or favorable Fed decisions typically boost stock prices, while negative news can trigger sell-offs. The speed and magnitude of price moves depends on whether the news beats or misses market expectations.

Question 3

What are stock market movers?

Accepted Answer

Stock market movers are stocks with significant price changes — either up (gainers) or down (losers) — within a trading session. Movers are typically driven by earnings reports, analyst upgrades or downgrades, macroeconomic news, or major corporate announcements. Kinvestor tracks the biggest movers in real time across the S&P 500, NASDAQ, and Dow Jones.

Question 4

What is earnings season?

Accepted Answer

Earnings season is the period each quarter when publicly traded companies report their financial results. It occurs four times per year: January–February (Q4 results), April–May (Q1 results), July–August (Q2 results), and October–November (Q3 results). During earnings season, stocks often experience heightened volatility as results beat or miss analyst expectations.

Question 5

What is financial intelligence?

Accepted Answer

Financial intelligence is the ability to understand and interpret financial data, market trends, news, and sentiment to make informed investment decisions. It combines real-time market data, news aggregation, sentiment analysis, and economic indicators into actionable insight. Kinvestor is a financial intelligence platform that aggregates these signals in one place.

Insider	Title	Type	Shares	Value	Date
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Exercise	5,000	$123.0K	1d ago
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Sell	9,000	$422.9K	1d ago
Nichols Christian Todd	SVP, Chief Commercial Officer	Sell	6,912	$340.0K	16d ago
Jackson Blair Curtis	President & CEO, Alkermes plc	Grant	93,229	—	28d ago
Gaffin David Joseph	EVP, CLO, Alkermes, Inc.	Sell	2,034	$98.8K	Aug 3, 2026
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Exercise	104	$2.0K	Aug 3, 2026
snyderman nancy lynn MD		Exercise	27,948	$1.3M	Aug 3, 2026
snyderman nancy lynn MD		Sell	44,472	$2.2M	Aug 3, 2026
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Sell	9,000	$437.2K	Aug 3, 2026
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Exercise	5,000	$0	Jun 1, 2026
Hopkinson Craig C.	EVP R&D, Chief Medical Officer	Sell	9,000	$0	Jun 1, 2026

Alkermes plc. (ALKS) Insider Trading